Dianthus Therapeutics, Inc. financial statements
Dianthus Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2.04M | 10-K |
| Net income | −USD 162.34M | 10-K |
| Cash and equivalents | USD 51.09M | 10-Q |
| Total debt | USD 1.39M | EODHD |
Dianthus Therapeutics, Inc. financials on 6ix · Dianthus Therapeutics, Inc. on 6ix